Social engagement
Social engagement: 1.4K social following, 10 posts in the last 12 months — below the industry typical range.
Recent activity
28 May 2026
Product launch
Obexelimab in IgG4-RD
19 May 2026
Product launch
DF5112
2 Mar 2026
Milestone
regulatory